Bioadaptives (BDPT) Cash & Current Investments (2019 - 2025)
Historic Cash & Current Investments for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $59273.0.
- Bioadaptives' Cash & Current Investments rose 3503.98% to $59273.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $59273.0, marking a year-over-year increase of 3503.98%. This contributed to the annual value of $137470.0 for FY2024, which is 12619.13% up from last year.
- As of Q3 2025, Bioadaptives' Cash & Current Investments stood at $59273.0, which was up 3503.98% from $210582.0 recorded in Q2 2025.
- Bioadaptives' 5-year Cash & Current Investments high stood at $210582.0 for Q2 2025, and its period low was $235.0 during Q2 2024.
- Over the past 5 years, Bioadaptives' median Cash & Current Investments value was $44513.0 (recorded in 2022), while the average stood at $61192.2.
- In the last 5 years, Bioadaptives' Cash & Current Investments plummeted by 9941.46% in 2024 and then skyrocketed by 8950936.17% in 2025.
- Quarter analysis of 5 years shows Bioadaptives' Cash & Current Investments stood at $83126.0 in 2021, then tumbled by 69.39% to $25447.0 in 2022, then surged by 138.83% to $60776.0 in 2023, then skyrocketed by 126.19% to $137470.0 in 2024, then plummeted by 56.88% to $59273.0 in 2025.
- Its Cash & Current Investments stands at $59273.0 for Q3 2025, versus $210582.0 for Q2 2025 and $39564.0 for Q1 2025.